Work

PILRA regulates microglial immunometabolism to reduce disease pathology as a candidate therapeutic target for Alzheimer's disease

Year: 2025

Type: article

Abstract: Lipidomics data analysis for the manuscript “PILRA regulates microglial immunometabolism to reduce disease pathology as a candidate therapeutic target for Alzheimer’s disease.” This archive contains a zipped, self-contained HTML project that includes the data and R code used for the analyses and visualizations presented in the manuscript.

Source: Zenodo (CERN European Organization for Nuclear Research)

DOI: 10.5281/zenodo.17155918

Authors: Weerakkody, Tanya N., Sabelström, Hanna, Monroe, Kathyrn M, Suh, Jung H.

Institution: Denali Therapeutics (United States)

Language: English

Topic: Neuroinflammation and Neurodegeneration Mechanisms

Subfield: Neurology

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W7082164442

FWCI:

Cites:

Cited by:

Related to: